23rd June 2022
We are excited to announce the seven start-ups from the DACH region that moves towards the Catapult semifinals!
Meet the start-ups selected from the DACH region to continue their EIT Health Catapult journey! They have been selected from 42 start-ups from across Europe and will advance to the next phase of the programme.
The DACH regional selection ended with the selection of:
⭐ Ablevia biotech GmbH [Austria, BioTech]
⭐ PRAMOMOLECULAR GmbH [Germany, BioTech]
⭐ Freiburger Medizintechnik GmbH [Germany, MedTech]
⭐ Biome Diagnostics [Austria, MedTech]
⭐ XUND [Austria, Digital Health]
⭐ deepeye [Germany, Digital Health]
⭐ edupression.com [Austria, Digital Health]
The 7 projects combine technology and product development in a way that is truly innovative and has the potential to create a better future for European citizens.
About
The EIT Health Austria in Vienna is the 8th RIH of EIT Health and started its setup in January 2022. The management board and team can be reached at Austria.Office@eithealth.eu.
Health experts make recommendations on EHDS implementation
Discover our new Think Tank report.
EIT Health-supported ABLE Human Motion receives CE mark
Learn how EIT Health has supported their journey.